Results 141 to 150 of about 7,492,718 (206)

Successful Treatment of Posttransplant Refractory Pure Red Cell Aplasia Following Parvovirus B19 Infection. [PDF]

open access: yesCase Rep Med
Ansara Y   +6 more
europepmc   +1 more source

Parvovirus B19 and Cellular Transcriptome Dynamics in UT7/EpoS1 Cells. [PDF]

open access: yesViruses
Guglietta N   +4 more
europepmc   +1 more source

Transplacental Infection: Frequency, Testing, and Treatment. [PDF]

open access: yesDtsch Arztebl Int
Härtel C   +4 more
europepmc   +1 more source

PARVOVIRUS B19 IN HUMAN DISEASE

open access: yesAnnual Review of Medicine, 1997
▪ Abstract  Parvovirus B19, the only known human pathogenic parvovirus, is associated with a wide range of disease manifestations. In healthy individuals, the major presentation of B19 infection is erythema infectiosum. In patients with underlying hemolytic disorders, infection is the primary cause of transient aplastic crisis.
K E, Brown, N S, Young
openaire   +3 more sources

Primary Infection by Human Parvovirus B19

open access: yesDermatology, 2009
We describe a case of primary infection by human parvovirus B19 in a 20-year-old woman; it manifested as erythemato-maculo-papular lesions, pharyngotonsillitis, lymphadenopathy, fever, arthralgia and myalgia, asthenia and anorexia. Laboratory tests revealed anaemia, leucopenia, thrombocytopaenia and a rise in some inflammatory indices.
S. Veraldi   +3 more
openaire   +4 more sources

Human Parvovirus B19 in Rheumatoid Arthritis

International Reviews of Immunology, 1998
Viral arthritis occurs transiently in most cases, because the infection is self limiting. The arthropathy associated with human parvovirus B19, however, often lasts for more than 2 years and their clinical symptoms may resemble with those of rheumatoid arthritis.
Takeshi Sasaki, K Sugamura
exaly   +3 more sources

Home - About - Disclaimer - Privacy